NYSE:SYK - Stryker Stock Price, Forecast & News

Stryker trades on the New York Stock Exchange (NYSE) under the ticker symbol "SYK."

Stryker announced a quarterly dividend on Thursday, December 5th. Shareholders of record on Tuesday, December 31st will be paid a dividend of $0.575 per share on Friday, January 31st. This represents a $2.30 dividend on an annualized basis and a dividend yield of 1.08%. The ex-dividend date is Monday, December 30th. This is a positive change from Stryker's previous quarterly dividend of $0.52. View Stryker's Dividend History.

Stryker Co. (NYSE:SYK) announced its quarterly earnings data on Tuesday, October, 29th. The medical technology company reported $1.91 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $1.90 by $0.01. The medical technology company had revenue of $3.59 billion for the quarter, compared to analyst estimates of $3.58 billion. Stryker had a return on equity of 25.33% and a net margin of 23.55%. Stryker's revenue was up 10.6% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.69 earnings per share. View Stryker's Earnings History.

Stryker is scheduled to release their next quarterly earnings announcement on Tuesday, January 28th 2020. View Earnings Estimates for Stryker.

Stryker will be holding an earnings conference call on Tuesday, January 28th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Stryker updated its fourth quarter earnings guidance on Tuesday, October, 29th. The company provided EPS guidance of $2.43 to $2.48 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.45.

20 brokers have issued twelve-month price objectives for Stryker's stock. Their forecasts range from $179.00 to $245.00. On average, they anticipate Stryker's stock price to reach $222.56 in the next twelve months. This suggests a possible upside of 4.9% from the stock's current price. View Analyst Price Targets for Stryker.

20 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Stryker in the last year. There are currently 6 hold ratings and 14 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Stryker.

Media stories about SYK stock have trended positive recently, InfoTrie Sentiment Analysis reports. InfoTrie rates the sentiment of press coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Stryker earned a media sentiment score of 2.2 on InfoTrie's scale. They also assigned media stories about the medical technology company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the stock's share price in the near term. View News Stories for Stryker.

Stryker saw a increase in short interest in December. As of December 31st, there was short interest totalling 3,910,000 shares, an increase of 10.8% from the December 15th total of 3,530,000 shares. Based on an average trading volume of 1,380,000 shares, the short-interest ratio is currently 2.8 days. Currently, 1.1% of the shares of the company are sold short. View Stryker's Current Options Chain.

Some companies that are related to Stryker include Medtronic (MDT), Abbott Laboratories (ABT), Becton Dickinson and (BDX), Intuitive Surgical (ISRG), Boston Scientific (BSX), Edwards Lifesciences (EW), Baxter International (BAX), IDEXX Laboratories (IDXX), ResMed (RMD), DexCom (DXCM), Teleflex (TFX), Hologic (HOLX), Varian Medical Systems (VAR), Steris (STE) and Insulet (PODD).

Based on aggregate information from My MarketBeat watchlists, some companies that other Stryker investors own include Johnson & Johnson (JNJ), Visa (V), Home Depot (HD), AbbVie (ABBV), Walt Disney (DIS), Abbott Laboratories (ABT), Medtronic (MDT), NVIDIA (NVDA), Bank of America (BAC) and CVS Health (CVS).

Stryker's stock is owned by many different of retail and institutional investors. Top institutional investors include Fenimore Asset Management Inc. (0.14%), Welch & Forbes LLC (0.14%), Boston Trust Walden Corp (0.10%), Commerzbank Aktiengesellschaft FI (0.09%), PGGM Investments (0.08%) and LGT Capital Partners LTD. (0.06%). Company insiders that own Stryker stock include Allan C Golston, Bijoy Sagar, David Floyd, Glenn S Boehnlein, Graham A Mclean, Howard E Cox Jr, Katherine Ann Owen, Kevin Lobo, Lonny J Carpenter, Louise Francesconi, M Kathryn Fink, Michael Damon Hutchinson, Roch Doliveux, Srikant M Datar, Timothy J Scannell, William E Berry Jr and Yin C Becker. View Institutional Ownership Trends for Stryker.

SYK stock was sold by a variety of institutional investors in the last quarter, including Meag Munich Ergo Kapitalanlagegesellschaft MBH, Tandem Investment Advisors Inc., OLD National Bancorp IN, Huntington National Bank, State of Alaska Department of Revenue, Tocqueville Asset Management L.P., Douglass Winthrop Advisors LLC and M&R Capital Management Inc.. Company insiders that have sold Stryker company stock in the last year include Allan C Golston, Bijoy Sagar, Glenn S Boehnlein, Katherine Ann Owen, Kevin Lobo, Louise Francesconi, M Kathryn Fink, Michael Damon Hutchinson, Srikant M Datar, Timothy J Scannell and Yin C Becker. View Insider Buying and Selling for Stryker.

SYK stock was purchased by a variety of institutional investors in the last quarter, including PGGM Investments, Commerzbank Aktiengesellschaft FI, Johanson Financial Advisors Inc., LVM Capital Management Ltd. MI, Abner Herrman & Brock LLC, GPM Growth Investors Inc., Fenimore Asset Management Inc. and LGT Capital Partners LTD.. View Insider Buying and Selling for Stryker.

Shares of SYK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of SYK stock can currently be purchased for approximately $212.17.

Stryker has a market capitalization of $79.37 billion and generates $13.60 billion in revenue each year. The medical technology company earns $3.55 billion in net income (profit) each year or $7.31 on an earnings per share basis. Stryker employs 36,000 workers across the globe.View Additional Information About Stryker.

The official website for Stryker is http://www.strykercorp.com/.

Stryker's mailing address is 2825 AIRVIEW BLVD, KALAMAZOO MI, 49002. The medical technology company can be reached via phone at 269-389-2600 or via email at [email protected]